CLEAR CELL SARCOMA OF THE KIDNEY

This adverse event was reported 4 times

CLEAR CELL SARCOMA OF THE KIDNEY is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 DACTINOMYCIN 1 0.0005
1 IFOSFAMIDE FOR INJECTION 1 0.0000
2 OSELTAMIVIR PHOSPHATE 1 0.0000
3 DOXORUBICIN HYDROCHLORIDE 1 0.0000
4 SUNITINIB MALATE 1 0.0000
5 DOXORUBICIN 2 0.0000
6 ETOPOSIDE 1 0.0000
7 CARBOPLATIN 1 0.0000
8 CYCLOPHOSPHAMIDE FOR INJECTION 1 0.0000
9 CYCLOPHOSPHAMIDE 1 0.0000
See all drugs enriched for association with CLEAR CELL SARCOMA OF THE KIDNEY

These drug classes are most commonly taken by patients reporting CLEAR CELL SARCOMA OF THE KIDNEY:

# Drug class Count
0 Alkylating Drug [EPC] 2
1 Actinomycin [EPC] 1
2 Platinum-based Drug [EPC] 1
3 Topoisomerase Inhibitor [EPC] 1
See all common drug classes associated with CLEAR CELL SARCOMA OF THE KIDNEY

CLEAR CELL SARCOMA OF THE KIDNEY is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Actinomycin [EPC] 1 0.0005
1 Topoisomerase Inhibitor [EPC] 1 0.0000
2 Alkylating Drug [EPC] 2 0.0000
3 Platinum-based Drug [EPC] 1 0.0000
See all drug classes enriched for association with CLEAR CELL SARCOMA OF THE KIDNEY